Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA |
ANCA Associated Vasculitis (AAV) | Phase2 | Brazil Israel Japan Saudi Arabia Singapore Switzerland United Kingdom United States View all |
NCT06868290 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors |
Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer | Phase1, Phase2 | Australia Canada China Czechia Denmark France Germany Israel Italy Japan Singapore South Korea Spain Taiwan United Kingdom United States View all |
NCT06726148 |
Modifying PEST for Psoriatic Arthritis Screening |
Plaque Psoriasis, Psoriatic Arthritis | Na | Canada | NCT06382051 |
LATAM LOWERS LDL-C |
Hypercholesterolaemia | Phase4 | Argentina Brazil |
NCT06501443 |
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis |
Generalized Myasthenia Gravis | Phase3 | Argentina Australia Belgium Brazil Canada China France Georgia Germany India Italy Japan Poland Romania Serbia South Korea Spain Taiwan United Kingdom United States View all |
NCT06744920 |
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. |
Chronic Myeloid Leukemia (CML) | Phase2 | France | NCT06514534 |
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Homozygous | Phase3 | Austria China Germany Greece Malaysia Netherlands South Africa Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT06597006 |
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence |
Breast Neoplasms | Austria Germany |
NCT06830720 | |
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever |
Dengue | Phase2 | Brazil Colombia India Malaysia Singapore Vietnam View all |
NCT06006559 |
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy |
Prostate Cancer | Phase2, Phase3 | Australia Brazil China Hong Kong Israel Japan Malaysia Singapore South Korea Switzerland Taiwan United States View all |
NCT06780670 |